1258 related articles for article (PubMed ID: 26041291)
21. Identification of Host Factors Involved in Human Cytomegalovirus Replication, Assembly, and Egress Using a Two-Step Small Interfering RNA Screen.
McCormick D; Lin YT; Grey F
mBio; 2018 Jun; 9(3):. PubMed ID: 29946045
[TBL] [Abstract][Full Text] [Related]
22. The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection.
Fehr AR; Channappanavar R; Jankevicius G; Fett C; Zhao J; Athmer J; Meyerholz DK; Ahel I; Perlman S
mBio; 2016 Dec; 7(6):. PubMed ID: 27965448
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of SARS-CoV replication by siRNA.
Wu CJ; Huang HW; Liu CY; Hong CF; Chan YL
Antiviral Res; 2005 Jan; 65(1):45-8. PubMed ID: 15652970
[TBL] [Abstract][Full Text] [Related]
24. Genome-scale CRISPR screens identify host factors that promote human coronavirus infection.
Grodzki M; Bluhm AP; Schaefer M; Tagmount A; Russo M; Sobh A; Rafiee R; Vulpe CD; Karst SM; Norris MH
Genome Med; 2022 Jan; 14(1):10. PubMed ID: 35086559
[TBL] [Abstract][Full Text] [Related]
25. The Nucleocapsid Proteins of SARS-CoV-2 and Its Close Relative Bat Coronavirus RaTG13 Are Capable of Inhibiting PKR- and RNase L-Mediated Antiviral Pathways.
LeBlanc K; Lynch J; Layne C; Vendramelli R; Sloan A; Tailor N; Deschambault Y; Zhang F; Kobasa D; Safronetz D; Xiang Y; Cao J
Microbiol Spectr; 2023 Jun; 11(3):e0099423. PubMed ID: 37154717
[TBL] [Abstract][Full Text] [Related]
26. Quantitative proteomics analysis reveals BAG3 as a potential target to suppress severe acute respiratory syndrome coronavirus replication.
Zhang L; Zhang ZP; Zhang XE; Lin FS; Ge F
J Virol; 2010 Jun; 84(12):6050-9. PubMed ID: 20392858
[TBL] [Abstract][Full Text] [Related]
27. A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets.
Kratzel A; Kelly JN; V'kovski P; Portmann J; Brüggemann Y; Todt D; Ebert N; Shrestha N; Plattet P; Staab-Weijnitz CA; von Brunn A; Steinmann E; Dijkman R; Zimmer G; Pfaender S; Thiel V
PLoS Biol; 2021 Dec; 19(12):e3001490. PubMed ID: 34962926
[TBL] [Abstract][Full Text] [Related]
28. Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity.
Menachery VD; Yount BL; Josset L; Gralinski LE; Scobey T; Agnihothram S; Katze MG; Baric RS
J Virol; 2014 Apr; 88(8):4251-64. PubMed ID: 24478444
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic and prophylactic potential of small interfering RNAs against severe acute respiratory syndrome: progress to date.
Chang Z; Babiuk LA; Hu J
BioDrugs; 2007; 21(1):9-15. PubMed ID: 17263585
[TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial derived cells and cardiomyocytes.
Li Y; Renner DM; Comar CE; Whelan JN; Reyes HM; Cardenas-Diaz FL; Truitt R; Tan LH; Dong B; Alysandratos KD; Huang J; Palmer JN; Adappa ND; Kohanski MA; Kotton DN; Silverman RH; Yang W; Morrisey E; Cohen NA; Weiss SR
bioRxiv; 2020 Nov; ():. PubMed ID: 32995797
[TBL] [Abstract][Full Text] [Related]
31. A molecular arms race between host innate antiviral response and emerging human coronaviruses.
Wong LY; Lui PY; Jin DY
Virol Sin; 2016 Feb; 31(1):12-23. PubMed ID: 26786772
[TBL] [Abstract][Full Text] [Related]
32. Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication.
Garcia G; Sharma A; Ramaiah A; Sen C; Purkayastha A; Kohn DB; Parcells MS; Beck S; Kim H; Bakowski MA; Kirkpatrick MG; Riva L; Wolff KC; Han B; Yuen C; Ulmert D; Purbey PK; Scumpia P; Beutler N; Rogers TF; Chatterjee AK; Gabriel G; Bartenschlager R; Gomperts B; Svendsen CN; Betz UAK; Damoiseaux RD; Arumugaswami V
Cell Rep; 2021 Apr; 35(1):108940. PubMed ID: 33784499
[TBL] [Abstract][Full Text] [Related]
33. Treatment of SARS with human interferons.
Cinatl J; Morgenstern B; Bauer G; Chandra P; Rabenau H; Doerr HW
Lancet; 2003 Jul; 362(9380):293-4. PubMed ID: 12892961
[TBL] [Abstract][Full Text] [Related]
34. Infectious Bronchitis Coronavirus Limits Interferon Production by Inducing a Host Shutoff That Requires Accessory Protein 5b.
Kint J; Langereis MA; Maier HJ; Britton P; van Kuppeveld FJ; Koumans J; Wiegertjes GF; Forlenza M
J Virol; 2016 Aug; 90(16):7519-7528. PubMed ID: 27279618
[TBL] [Abstract][Full Text] [Related]
35. Novel rapid immunochromatographic test based on an enzyme immunoassay for detecting nucleocapsid antigen in SARS-associated coronavirus.
Kogaki H; Uchida Y; Fujii N; Kurano Y; Miyake K; Kido Y; Kariwa H; Takashima I; Tamashiro H; Ling AE; Okada M
J Clin Lab Anal; 2005; 19(4):150-9. PubMed ID: 16025480
[TBL] [Abstract][Full Text] [Related]
36. The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors.
Pfefferle S; Schöpf J; Kögl M; Friedel CC; Müller MA; Carbajo-Lozoya J; Stellberger T; von Dall'Armi E; Herzog P; Kallies S; Niemeyer D; Ditt V; Kuri T; Züst R; Pumpor K; Hilgenfeld R; Schwarz F; Zimmer R; Steffen I; Weber F; Thiel V; Herrler G; Thiel HJ; Schwegmann-Wessels C; Pöhlmann S; Haas J; Drosten C; von Brunn A
PLoS Pathog; 2011 Oct; 7(10):e1002331. PubMed ID: 22046132
[TBL] [Abstract][Full Text] [Related]
37. Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies.
Davies JP; Almasy KM; McDonald EF; Plate L
ACS Infect Dis; 2020 Dec; 6(12):3174-3189. PubMed ID: 33263384
[TBL] [Abstract][Full Text] [Related]
38. Restriction of SARS-CoV-2 replication by receptor transporter protein 4 (RTP4).
Kaur R; Tada T; Landau NR
mBio; 2023 Aug; 14(4):e0109023. PubMed ID: 37382452
[TBL] [Abstract][Full Text] [Related]
39. Coronavirus nonstructural protein 1: Common and distinct functions in the regulation of host and viral gene expression.
Narayanan K; Ramirez SI; Lokugamage KG; Makino S
Virus Res; 2015 Apr; 202():89-100. PubMed ID: 25432065
[TBL] [Abstract][Full Text] [Related]
40. Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpain.
Schneider M; Ackermann K; Stuart M; Wex C; Protzer U; Schätzl HM; Gilch S
J Virol; 2012 Sep; 86(18):10112-22. PubMed ID: 22787216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
